• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PHH3在评估乳腺癌有丝分裂指数中的应用及其对肿瘤分级的影响。

Utility of PHH3 in Evaluation of Mitotic Index in Breast Carcinoma and Impact on Tumor Grade.

作者信息

Mirzaiian Elham, Tabatabaei Ghods Zahra Sadat, Tavangar Seyed Mohammad, Emami Binesh, Oraie Maryam, Safyari Roya, Saffar Hiva

机构信息

Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Anatomical and Clinical Pathologist, Farvardin Laboratory, Tehran, Iran.

出版信息

Asian Pac J Cancer Prev. 2020 Jan 1;21(1):63-66. doi: 10.31557/APJCP.2020.21.1.63.

DOI:10.31557/APJCP.2020.21.1.63
PMID:31983165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7294007/
Abstract

BACKGROUND

Mitotic activity index is considered as the most important grading component to predict prognosis in invasive breast carcinoma. But it is believed that it is also the cause of discordance in grade estimation based on Bloom-Richardson system. Thus, reproducible methods such as immunohistochemistry (IHC) based analysis methods appears to be of great value in facilitating mitotic count.

MATERIALS AND METHODS

In the present study, we examined the utility of Phosphohistone H3 by IHC in various grades of breast carcinoma and compared it with traditional mitotic count by hematoxylin and eosin (H and E) staining and probable changes in tumor grading.

RESULTS

Total 90 cases of invasive breast carcinoma were evaluated. Mean mitotic count were 8.6 and 6.4/10HPF in IHC and HandE groups, respectively. Although , mean average count was higher by IHC method , good correlation was observed(R=0.914). Using PHH3 IHC, two out of 33 cases of grade I tumors were upgraded in to grade II and three cases of grade II were upgraded in to grade III. None of the tumors were down graded.

CONCLUSION

Similar to some other previous studies, we found PHH3 a robust sensitive and practical marker for mitotic count in breast carcinoma. Especially it is helpful to identify the most proliferating area. However, further studies are required to confirm the superiority of this biomarker for including in grading system.
.

摘要

背景

有丝分裂活性指数被认为是预测浸润性乳腺癌预后的最重要分级组成部分。但据信它也是基于布鲁姆-理查森系统的分级评估中出现不一致的原因。因此,诸如基于免疫组织化学(IHC)的分析方法等可重复的方法在促进有丝分裂计数方面似乎具有很大价值。

材料与方法

在本研究中,我们检测了免疫组织化学法检测磷酸化组蛋白H3在不同分级乳腺癌中的应用,并将其与苏木精和伊红(H&E)染色的传统有丝分裂计数以及肿瘤分级可能的变化进行了比较。

结果

共评估了90例浸润性乳腺癌病例。免疫组织化学组和苏木精和伊红染色组的平均有丝分裂计数分别为8.6和6.4/10高倍视野。虽然免疫组织化学法的平均计数较高,但观察到良好的相关性(R = 0.914)。使用磷酸化组蛋白H3免疫组织化学法,33例I级肿瘤中有2例升级为II级,3例II级肿瘤升级为III级。没有肿瘤降级。

结论

与其他一些先前的研究相似,我们发现磷酸化组蛋白H3是乳腺癌有丝分裂计数的一种可靠、敏感且实用的标志物。特别是它有助于识别增殖最活跃的区域。然而,需要进一步研究来证实这种生物标志物在纳入分级系统方面的优越性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f88c/7294007/ab27a860a1ca/APJCP-21-063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f88c/7294007/ab27a860a1ca/APJCP-21-063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f88c/7294007/ab27a860a1ca/APJCP-21-063-g001.jpg

相似文献

1
Utility of PHH3 in Evaluation of Mitotic Index in Breast Carcinoma and Impact on Tumor Grade.PHH3在评估乳腺癌有丝分裂指数中的应用及其对肿瘤分级的影响。
Asian Pac J Cancer Prev. 2020 Jan 1;21(1):63-66. doi: 10.31557/APJCP.2020.21.1.63.
2
Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.磷酸组蛋白 H3(PHH3)作为脑膜瘤分级中有丝分裂像计数的替代物:PHH3(S10)与 PHH3(S28)抗体的比较。
Virchows Arch. 2019 Jan;474(1):87-96. doi: 10.1007/s00428-018-2458-2. Epub 2018 Sep 29.
3
Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.看得更仔细才能更好地达成一致:磷酸化组蛋白H3提高了脑膜瘤分级中有丝分裂计数的观察者间一致性,并设定了新的特定阈值。
Neuro Oncol. 2015 May;17(5):663-9. doi: 10.1093/neuonc/nov002. Epub 2015 Feb 1.
4
Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.磷酸组蛋白 H3 免疫组化染色的有丝分裂计数可预测生存并提高胰腺高分化神经内分泌肿瘤的观察者间可重复性。
Am J Surg Pathol. 2015 Jan;39(1):13-24. doi: 10.1097/PAS.0000000000000341.
5
Phosphohistone H3 expression correlates with manual mitotic counts and aids in identification of "hot spots" in fibroepithelial tumors of the breast.磷酸化组蛋白H3的表达与手动有丝分裂计数相关,并有助于识别乳腺纤维上皮性肿瘤中的“热点”。
Hum Pathol. 2016 Mar;49:90-8. doi: 10.1016/j.humpath.2015.10.012. Epub 2015 Nov 5.
6
Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.利用磷酸化组蛋白 H3(PHH3)抗体与苏木精和伊红复染,提高有丝分裂细胞计数的准确性和效率,作为乳腺癌分级的一部分。
Histopathology. 2023 Feb;82(3):393-406. doi: 10.1111/his.14837. Epub 2022 Nov 18.
7
The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.磷酸化组蛋白H3辅助有丝分裂计数和Ki67评分在高分化胰腺神经内分泌肿瘤的肿瘤分级判定及远处转移预测中的作用
Endocr Pathol. 2016 Jun;27(2):162-70. doi: 10.1007/s12022-016-9424-9.
8
Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia.在口腔上皮异型增生中,有丝分裂计数和 PHH3 表达的预后意义。
Virchows Arch. 2024 Jan;484(1):47-59. doi: 10.1007/s00428-023-03668-6. Epub 2023 Oct 26.
9
Validation of mitosis counting by automated phosphohistone H3 (PHH3) digital image analysis in a breast carcinoma tissue microarray.通过自动磷酸化组蛋白H3(PHH3)数字图像分析对乳腺癌组织微阵列中的有丝分裂计数进行验证。
Pathology. 2015 Jun;47(4):329-34. doi: 10.1097/PAT.0000000000000248.
10
Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma.通过磷酸化组蛋白H3免疫组织化学测定有丝分裂指数用于滤泡性淋巴瘤的精确分级
Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):579-585. doi: 10.1097/PAI.0000000000000481.

引用本文的文献

1
Information mismatch in PHH3-assisted mitosis annotation leads to interpretation shifts in H&E slide analysis.PHH3 辅助有丝分裂标注中的信息不匹配导致 H&E 切片分析的解读发生转变。
Sci Rep. 2024 Nov 1;14(1):26273. doi: 10.1038/s41598-024-77244-6.
2
A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms.一项关于 PHH3、Ki67 和 P53 在膀胱外生性乳头状尿路上皮肿瘤中的表达及临床意义的回顾性研究。
PeerJ. 2023 Jul 11;11:e15675. doi: 10.7717/peerj.15675. eCollection 2023.
3
Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.

本文引用的文献

1
Anti-Phosphohistone H3-Positive Mitoses Are Linked to Pathological Response in Neoadjuvantly Treated Breast Cancer.抗磷酸化组蛋白H3阳性有丝分裂与新辅助治疗的乳腺癌的病理反应相关。
Breast Care (Basel). 2017 Sep;12(4):244-250. doi: 10.1159/000463377. Epub 2017 Aug 2.
2
The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67.磷酸化组蛋白H3作为评估浸润性乳腺癌增殖标志物的价值:与Ki67的比较研究
Oncotarget. 2017 May 10;8(39):65064-65076. doi: 10.18632/oncotarget.17775. eCollection 2017 Sep 12.
3
Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients.
利用磷酸化组蛋白 H3(PHH3)抗体与苏木精和伊红复染,提高有丝分裂细胞计数的准确性和效率,作为乳腺癌分级的一部分。
Histopathology. 2023 Feb;82(3):393-406. doi: 10.1111/his.14837. Epub 2022 Nov 18.
4
Determination of β-catenin Expression in Breast Cancer and Its Relationship with Clinicopathologic Parameters.β-连环蛋白在乳腺癌中的表达及其与临床病理参数的关系。
Asian Pac J Cancer Prev. 2021 Nov 1;22(11):3493-3498. doi: 10.31557/APJCP.2021.22.11.3493.
作为乳腺癌患者预后的标志物,磷酸化组蛋白H3比Ki67表现更优。
Histopathology. 2015 Oct;67(4):538-47. doi: 10.1111/his.12678. Epub 2015 Mar 31.
4
The Utility of Phosphohistone H3 in Breast Cancer Grading.磷酸化组蛋白H3在乳腺癌分级中的应用
Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):689-95. doi: 10.1097/PAI.0000000000000137.
5
Assessment of algorithms for mitosis detection in breast cancer histopathology images.乳腺癌组织病理学图像有丝分裂检测算法的评估。
Med Image Anal. 2015 Feb;20(1):237-48. doi: 10.1016/j.media.2014.11.010. Epub 2014 Nov 29.
6
Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program.组织学分级仍然是乳腺癌的预后因素,与阳性淋巴结的数量和肿瘤大小无关:来自 SEER 计划的 161708 例乳腺癌研究。
Arch Pathol Lab Med. 2014 Aug;138(8):1048-52. doi: 10.5858/arpa.2013-0435-OA.
7
Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases.当前的乳腺癌增殖标志物根据细胞周期各阶段解耦的持续时间呈现出不同的相关性。
Sci Rep. 2014 May 30;4:5122. doi: 10.1038/srep05122.
8
Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.免疫检测磷酸组蛋白 H3 作为皮肤黑色素瘤有丝分裂计数和临床结果的替代指标。
Mod Pathol. 2013 Sep;26(9):1153-60. doi: 10.1038/modpathol.2013.59. Epub 2013 Apr 5.
9
Anti-phosphohistone H3 as an independent prognostic factor in human esophageal squamous cell carcinoma.抗组蛋白 H3 作为人食管鳞状细胞癌的独立预后因素。
Anticancer Res. 2013 Feb;33(2):461-7.
10
Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma.免疫组织化学双重染色作为评估黑色素瘤有丝分裂活性的辅助方法。
J Cutan Pathol. 2012 Mar;39(3):324-30. doi: 10.1111/j.1600-0560.2011.01858.x.